REBEL Cast brings REBEL EM posts to life in audio form. We open with a clinical scenario and a focused clinical question, then critically appraise the study—key results, strengths, limitations, and what it means at the bedside. Every episode ends with actionable take-home points.

Have a paper we should review? Email: rebelemteam@gmail.com.

Listen: 

REBEL Cast Episode 39 – The TOAST Trial: Dexamethasone for Acute Pharyngitis

Background: Sore throat is a common presentation to the emergency department as well as primary care clinics.  Corticosteroids inhibit transcription of pro-inflammatory mediators in airway endothelial cells responsible for pharyngeal inflammation and symptoms of pain.  They have been used in ...

Read More
Head, Eye, Ear, Nose, and Throat

Episode 38 – Do All Submassive PE’s Require Treatment with Thrombolysis?

Background: There has been very little robust evidence published on the long-term outcomes of systemic thrombolysis in acute submassive PE.  Many advocate for the use of systemic thrombolysis to reduce morbidity (complications from chronic pulmonary hypertension) and mortality. The PEITHO ...

Read More
Thoracic and Respiratory

Episode 37 – Definitions and Identification of Sepsis: Sepsis 2.0 vs Sepsis 3.0

Background: Just a few months ago the surviving sepsis campaign published their international guidelines for management of sepsis and septic shock .  There has been a lot of talk in the FOAM world about sepsis 3.0 and this is the ...

Read More
Infectious Disease

Episode 35 – Non Operative Treatment of Appendicitis (NOTA)

Background: Historically the treatment of uncomplicated appendicitis has been appendectomy. The first appendectomy performed dates back to 1735 done by Claudius Amyand. Appendectomy has been the standard treatment for acute appendicitis every since Charles McBurney described it in 1889. However, studies have shown ...

Read More
Infectious Disease

Episode 34 – The Death of Mechanical CPR (mCPR)?

Background: The two most important things that we can do in cardiac arrest to improve survival and neurologically intact outcomes is high quality CPR, with limited interruptions and early defibrillation. In the case of the former, the 2015 AHA/ACC CPR updates ...

Read More
Resuscitation

February 2017 REBEL Cast: The All Hyperoxia Edition

Background: Many providers and health care workers place oxygen on patients as a way to overcome hypoxemia or for patient comfort. Also in STEMI patients, many of us have learned the mnemonic “MONA” to remember the treatments for acute coronary ...

Read More
Resuscitation

REBEL Cast Episode 31: Obstructive Left Main Coronary Artery Disease

The standard treatment for patients with obstructive left main coronary artery disease has typically been coronary-artery bypass grafting (CABG), however some newer trials have suggested that maybe drug-eluting stents may be an acceptable alternative to CABG in select patients. In ...

Read More
Cardiovascular

REBEL Cast Episode 30: The PESIT Trial – Do All Patients with 1st Time Syncope Need a Pulmonary Embolism Workup?

Background: Syncope is a very frustrating chief complaint for many in the medical field.  There is no gold standard test and no validated decision instrument. It represents about 3 – 5% of ED visits, 1 – 6% of hospital admissions, ...

Read More
Thoracic and Respiratory

REBEL Cast Episode 29: IDSA Pneumonia Update

Every few years we get updates in the guidelines based on new evidence. Guidelines give us a framework to work with in the treatment of disease processes, such as pneumonia. The last Infectious Disease Society of America (IDSA) guidelines update ...

Read More
Infectious Disease

REBEL Cast Episode 28: Refractory Ventricular Fibrillation

Background: Welcome back to the September 2016 REBEL Cast. We are back with another episode and I am super excited about this episode because we are going to talk about two papers just published in the Resuscitation Journal on management ...

Read More
CardiovascularResuscitation
Showing Slide 1 of 11
Get new posts (free)

1 email per week. No spam.

Sponsored